Standout Papers

The Antianginal Drug Trimetazidine Shifts Cardiac Energy Metabolism From Fatty Acid Oxidation ... 2000 2026 2008 2017 609
  1. The Antianginal Drug Trimetazidine Shifts Cardiac Energy Metabolism From Fatty Acid Oxidation to Glucose Oxidation by Inhibiting Mitochondrial Long-Chain 3-Ketoacyl Coenzyme A Thiolase (2000)
    Paul F. Kantor, Arnaud Lucien et al. Circulation Research

Immediate Impact

1 by Nobel laureates 6 from Science/Nature 59 standout
Sub-graph 1 of 21

Citing Papers

Myocardial Metabolomics of Human Heart Failure With Preserved Ejection Fraction
2023 Standout
Right Ventricular Failure
2023 Standout
3 intermediate papers

Works of Arnaud Lucien being referenced

The Antianginal Drug Trimetazidine Shifts Cardiac Energy Metabolism From Fatty Acid Oxidation to Glucose Oxidation by Inhibiting Mitochondrial Long-Chain 3-Ketoacyl Coenzyme A Thiolase
2000 Standout
Trimetazidine increases phosppholipid turnover in ventricular myocyte
1997

Author Peers

Author Last Decade Papers Cites
Arnaud Lucien 228 458 36 182 17 768
J. S. Ingwall 364 505 28 249 20 942
Helena Tuunanen 230 533 72 190 21 876
Morgan He 333 271 24 109 18 786
Sarah L. Henning 429 455 38 113 8 786
Pericle Di Napoli 197 400 50 135 26 861
Michaela Scheuermann‐Freestone 245 565 56 190 11 832
Harper K. Hellems 150 456 47 155 35 934
J T Whitmer 356 388 28 161 10 798
Kenichi Arimura 312 315 37 78 8 691
Anastassia Todor 326 490 25 60 18 812

All Works

Loading papers...

Rankless by CCL
2026